This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Coca-Cola (KO) Rises as Q3 Earnings & Revenues Beat, Ups View
by Zacks Equity Research
Coca-Cola (KO) Q3 results gain from recovery across markets, strategic transformation, and improvements in at-home and away-from-home channels.
Archer Daniels (ADM) Surpasses Q3 Earnings & Revenue Estimates
by Zacks Equity Research
Archer Daniels' (ADM) Q3 results reflect gains from solid revenues across all segments, owing to healthy product demand. It expects strong momentum to continue in Q4.
Inter Parfums (IPAR) Raises 2021 View Again on Solid Q3 Sales
by Zacks Equity Research
Inter Parfums (IPAR) reported record sales numbers for the third quarter of 2021, reflecting impressive brand performance. Also, management revises 2021 view upward.
Philip Morris (PM) Q3 Earnings & Revenues Beat Mark, Rise Y/Y
by Zacks Equity Research
Philip Morris' (PM) third-quarter 2021 results reflect higher earnings and revenues with favorable pricing variance being an upside.
Coty (COTY) Gains on Strength in Partnerships & Core Priorities
by Zacks Equity Research
Coty (COTY) focuses on undertaking several strategic partnerships to enhance its brand portfolio. The company's e-commerce business is performing impressively.
Procter & Gamble (PG) Q1 Earnings Beat, Cost View Hurts Stock
by Zacks Equity Research
Procter & Gamble's (PG) Q1 results reflect sales growth across all segments, while higher costs hurt the operating margin. The increased cost view hurts investor sentiments.
The Estee Lauder Companies (EL) Gains on Online & Skin Care Sales
by Zacks Equity Research
Strength in The Estee Lauder Companies' (EL) Skin Care portfolio is a major driver. Also, the company is implementing stringent cost-curtailment practices.
Nu Skin's (NUS) Solid Innovations Aid, Pandemic-Led Hurdles Hurt
by Zacks Equity Research
Nu Skin (NUS) is benefiting from effective product launches. However, the company is battling challenges stemming from the spread of the delta variant across several markets.
Helen of Troy (HELE) Q2 Earnings Top Estimates, Sales Down
by Zacks Equity Research
Helen of Troy's (HELE) second-quarter fiscal 2022 results reflect a decline in earnings and net sales due to weakness in the Health & Home segment.
Archer Daniels (ADM) Gains on Solid Nutrition Unit, High Demand
by Zacks Equity Research
Despite cost woes, Archer Daniels (ADM) is likely to continue gaining from healthy demand, strength in the Nutrition unit and other growth efforts, including its Readiness program.
Company News for Oct 8, 2021
by Zacks Equity Research
Companies in The News Are: LEVI, HELE, LW, TWTR.
Company News for Oct 8, 2021
by Zacks Equity Research
Companies in The News Are: LEVI, HELE, LW, TWTR.
Molson Coors (TAP) Expands CBD Beverage Line With Truss USA
by Zacks Equity Research
Molson Coors (TAP) is likely to strengthen its position in the cannabis beverage market by expanding its Veryvell CBD beverages line through Truss USA.
Helen of Troy (HELE) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 24.41% and 9.60%, respectively, for the quarter ended August 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights: Estee Lauder, Coty. Helen of Troy and Inter Parfums
by Zacks Equity Research
Zacks Industry Outlook Highlights: Estee Lauder, Coty. Helen of Troy and Inter Parfums
4 Cosmetics Stocks Looking Good on Favorable Demand Trends
by Vidya Nair
The Zacks Cosmetics industry gains on higher demand amid consumers' increased outdoor movement. Such trends along with product launches are aiding companies like Estee Lauder (EL), Coty (COTY), Helen of Troy (HELE) and Inter Parfums (IPAR).
Nu Skin (NUS) Lowers Q3 Revenue View Amid Pandemic-Led Hurdles
by Zacks Equity Research
Nu Skin (NUS) expects Q3 revenues in the band of $637-$642 million, lower than the previous range. Challenges caused by the delta variant across several markets are a downside.
Inter Parfums (IPAR) Finalizes Licensing Deal With Ferragamo
by Zacks Equity Research
Inter Parfums (IPAR) finalizes exclusive worldwide license deal for the production and distribution of Salvatore Ferragamo brand perfumes.
Helen of Troy (HELE) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Helen of Troy's (HELE) second-quarter fiscal 2022 results are likely to reflect the adverse impacts related to the Environmental Protection Agency matter. Also, elevated costs are a worry.
Coty (COTY) Unveils Plans to Offload 9% Stake in Wella To KKR
by Zacks Equity Research
Coty (COTY) signs an agreement to offload nearly 9% stake in Wella to KKR. Through the deal, management expects to simplify Coty's capital structure.
Inter Parfums (IPAR) Teams Up With G-III Apparel to Boost Growth
by Zacks Equity Research
Inter Parfums (IPAR) enters into a licensing agreement with G-III Apparel to create, develop as well as distribute fragrances and related items.
Earnings Preview: Helen of Troy (HELE) Q2 Earnings Expected to Decline
by Zacks Equity Research
Helen of Troy (HELE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Coty (COTY) Teams Up With Perfect Corp. to Accelerate Growth
by Zacks Equity Research
Coty (COTY) signs a multi-channel agreement with Perfect Corp. to help customers shop in the most convenient and personalized manner both online and offline.
Why a Hold Strategy is Apt for Constellation Brands (STZ) Now
by Zacks Equity Research
Constellation Brands (STZ) gains from the strength in the beer business, and robust shipment and depletion growth. Softness in the wine and spirits business, and Canopy-related costs are concerning.
The Estee Lauder Companies (EL) Gains on Skin Care, Online Strength
by Zacks Equity Research
The Estee Lauder Companies (EL) is implementing new technology and digital experiences to boost growth. Also, the company's Skin Care portfolio is performing well.